Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21959-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#21959-1-AP, RRID:AB_11182396
- Product name
- FTCD antibody
- Antibody type
- Polyclonal
- Description
- FTCD antibody (Cat. #21959-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Significance of Liver Zonation in Hepatocellular Carcinoma.
A novel four-gene of iron metabolism-related and methylated for prognosis prediction of hepatocellular carcinoma.
Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway.
Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.
Yu S, Gao J, Wang H, Liu L, Liu X, Xu Y, Shi J, Guo W, Zhang S
Frontiers in cell and developmental biology 2022;10:806408
Frontiers in cell and developmental biology 2022;10:806408
A novel four-gene of iron metabolism-related and methylated for prognosis prediction of hepatocellular carcinoma.
Shen H, Wu H, Sun F, Qi J, Zhu Q
Bioengineered 2021 Dec;12(1):240-251
Bioengineered 2021 Dec;12(1):240-251
Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway.
Chen J, Chen Z, Huang Z, Yu H, Li Y, Huang W
Medical science monitor : international medical journal of experimental and clinical research 2019 Jun 16;25:4474-4484
Medical science monitor : international medical journal of experimental and clinical research 2019 Jun 16;25:4474-4484
Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.
Gao Y, Wang X, Sang Z, Li Z, Liu F, Mao J, Yan D, Zhao Y, Wang H, Li P, Ying X, Zhang X, He K, Wang H
Scientific reports 2017 Apr 5;7:45913
Scientific reports 2017 Apr 5;7:45913
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse liver tissue were subjected to SDS PAGE followed by western blot with 21959-1-AP(FTCD antibody) at dilution of 1:1000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human kidney using 21959-1-AP(FTCD antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FTCD antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human FTCD. This antibody recognizes human,mouse,rat antigen. The FTCD antibody has been validated for the following applications: ELISA, WB, IHC analysis.
